

Thursday
August 7, 2025
4:05 PM ET
Trevi Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates
Thursday
July 31, 2025
4:05 PM ET
Trevi Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 7, 2025
Sunday
June 1, 2025
4:00 PM ET
Trevi Therapeutics to Host Conference Call and Webcast on June 2nd to Share Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough
Thursday
May 8, 2025
4:05 PM ET
Trevi Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates
Thursday
May 1, 2025
4:05 PM ET
Trevi Therapeutics to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 8, 2025
Tuesday
March 18, 2025
4:05 PM ET
Trevi Therapeutics Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Updates
Tuesday
March 11, 2025
4:05 PM ET
Trevi Therapeutics to Report Fourth Quarter and Year End 2024 Financial Results and Provide a Corporate Update on March 18, 2025
Sunday
March 9, 2025
4:00 PM ET
Trevi Therapeutics to Host Conference Call and Webcast on March 10th to Share Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough